J&J News - Facebook
J&J News. 55,466 likes · 4,460 talking about this. J&J News brings you all the facts.
Latest news - Johnson & Johnson
Oct 10, 2024 · A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
J&J beats Wall St estimates on strong drug sales ahead of Stelara ...
July 17 (Reuters) - Johnson & Johnson (JNJ.N) beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and...
The battle over J&J’s bankruptcy plan to end talc lawsuits
Jul 8, 2024 · Johnson & Johnson is locked in a bitter fight with lawyers opposing its third attempt to settle tens of thousands of lawsuits through a controversial bankruptcy-court maneuver. The women alleging...
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
Jan 8, 2024 · J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion. Johnson & Johnson said it will acquire Ambrx Biopharma for $2 billion, picking up a drugmaker specializing in one of the ...
J&J to pump another $13B into its MedTech ... - Associated Press News
Apr 5, 2024 · Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
J&J plans to split into two companies, separating consumer ... - CNBC
Nov 12, 2021 · Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded...
J&J to buy Shockwave Medical in $13.1 billion acquisition - USA TODAY
Apr 5, 2024 · Johnson & Johnson announced Friday it will buy medical device maker Shockwave Medical for nearly $13.1 billion in a move the company hopes will help it further combat heart disease.
Johnson & Johnson to pay $6.5 billion to resolve nearly all ... - NBC News
May 1, 2024 · Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian...
Positive New Data for Johnson & Johnson Single-Shot COVID-19 …
NEW BRUNSWICK, N.J., July 1, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 …
- Some results have been removed